Capricor Therapeutics Inc (NASDAQ:CAPR)
| 6.00 Delayed Data As of Sep 30 |  +0.07 / +1.18%Today’s Change | 2.56 Today|||52-Week Range 6.21 | +104.78% Year-to-Date |
Latest CAPR News | Press Releases
No recent news for Capricor Therapeutics Inc.
Today’s Trading
| Previous close | 5.93 |
| Today’s open | 6.03 |
| Day’s range | 5.96 - 6.17 |
| Volume | 12,827 |
| Average volume (3 months) | 161,219 |
| Market cap | $146.1M |
Data as of 4:01pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +1.13% |
| Earnings growth (this year) | -37.93% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -21.06% |
| P/E ratio | NM |
| Price/Sales | 276.24 |
| Price/Book | 4.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTKParatek Pharmaceutic... | +0.07 | +2.79% |
| MTNBMatinas BioPharma Ho... | +0.03 | +5.35% |
| ATXSAstria Therapeutics ... | +0.23 | +2.58% |
| ---- |
Data as of 4:01pm ET, 09/30/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $244.9K |
| Annual profit (last year) | -$20.0M |
| Net profit margin | -8,175.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
